Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Prestige Brands Q4: The OTC marketer will leverage the success of last season's Chloraseptic liquid center lozenge with the upcoming introduction of a maximum strength lozenge as well as a spray form, according to a May 15 release. In the January-March period, the Irvington, N.Y.-based firm's OTC healthcare business advanced 7 percent to $46.2 million, benefiting from growth of Murine Earigate as well as double-digit growth of Clear Eyes on the launch of Maximum Redness, Prestige Brands reports May 15. Net sales rose 3 percent to $80.4 million and net income grew 24 percent to $10.4 million, the firm notes. For its fiscal year 2008, Prestige Brands' net revenues grew 3 percent to $326.6 million, though net income fell 6 percent to $33.9 million due to a favorable tax benefit in 2007, the firm notes...